LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL Cassie Kline , Angela J Waanders , David S Ziegler , Lindsay B Kilburn , Karsten Nysom , Jasper van der Lugt , Timothy E Hassall , Nicolas U Gerber , Devorah Segal , Valérie Larouche , Dong-Anh Khuong-Quang , Jordan R Hansford , Sarah E S Leary , Pablo Hernáiz Driever , Simon Bailey , Sébastien Perreault , Geoffrey McCowage , Olaf Witt , Patricia A Baxter , Hyoung Jin Kang , Jung Woo Han , Darren Hargrave , Andrea T Franson , Michal Yalon Oren , Helen Toledano , Mohamed S Abdelbaki , Nada Jabado , Nicholas G Gottardo , Nicholas S Whipple , Susan N Chi , Liat Oren , Enrica E K Tan , Sabine Mueller , Karen D Wright , Samuel C Blackman , Jiaheng Qiu , Dolores Podesta , Ashley Walter , Daniel Da Costa , Peter Manley , Lisa McLeod , Daniel B Landi Neuro-Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
